Dark Watch | $3,500,000 | (Mar 17, 2026)
Alomana | $4,597,680 | (Mar 17, 2026)
Gangkhar | $4,250,000 | (Mar 17, 2026)
Ablaze Pharmaceuticals
China
- Shanghai
- 29/11/2021
- Series A
- $75,000,000
Ablaze Pharma is a clinical stage Biopharmaceutical Company which is focused on the developing innovative Targeted Radiotherapy (TRT) to benefit cancer patients in China.
- Industry Pharmaceutical Manufacturing
- Website http://www.ablazepharma.com/
- LinkedIn https://www.linkedin.com/company/ablaze-pharmaceuticals-shanghai-co-ltd/
Related People
Tiecheng Alex QiaoFounder
United States -
San Diego, California,
Serial Entrepreneur experienced in high tech start ups. Twenty years of extensive knowledge in managing complex technologies and technology product development. A proven track record of conceiving and growing companies from concept to successful market entry, developing new product concepts, sourcing and managing co-development activities both in US and in China. Demonstrated success in building and leading multi-functional teams, strategic planning, and decision making. Also an inventor with 25 issued US patents and experience in developing and managing Intellectual Property.
Specialties: Conceiving and developing high tech business from concept to commercial success. Team building in high tech start up companies. Integrated product development and commercialization.
Malama Health | $9,200,000 | (Mar 17, 2026)
Great Sky | $14,000,000 | (Mar 17, 2026)
Understood Care | $5,000,000 | (Mar 17, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)
Certiv | $4,200,000 | (Mar 17, 2026)
Scanner | $22,000,000 | (Mar 17, 2026)
Zero RFI | $13,800,000 | (Mar 17, 2026)
Nadia Care | $12,000,000 | (Mar 17, 2026)
Eileen Inc. | $1,000,000 | (Mar 17, 2026)
Halcyon(US) | $21,000,000 | (Mar 17, 2026)